Keyphrases
Societal Costs
100%
1-year Follow-up
100%
Societal Quality
100%
Resective Epilepsy Surgery
100%
Quality of Life Analysis
100%
Drug-resistant Epilepsy
33%
Disease-specific Quality of Life
33%
Generic Health-related Quality of Life
33%
Long Follow-up
16%
Seizure Frequency
16%
Clinically Significant
16%
Dutch
16%
After Surgery
16%
Linear Mixed Model
16%
Epilepsy Patients
16%
Treatment Efficacy
16%
Quality of Life Improvement
16%
Validated Questionnaire
16%
Large Sample Size
16%
Disease-specific
16%
First Year
16%
Cost-effectiveness Study
16%
Cost-effectiveness Analysis
16%
Seizure Reduction
16%
Productivity Loss
16%
Economic Outcomes
16%
Medical Consumption
16%
Mixed-effects Logistic Regression
16%
Seizure Freedom
16%
Mixed Model ANOVA
16%
Clinical Outcomes
16%
INIS
patients
100%
surgery
100%
epilepsy
100%
quality of life
100%
societal costs
100%
diseases
37%
reduction
25%
drugs
25%
cost
12%
size
12%
losses
12%
economics
12%
productivity
12%
cost effectiveness analysis
12%
Medicine and Dentistry
Health Care Cost
100%
Epilepsy Surgery
100%
Quality of Life Analysis
100%
Quality of Life
83%
Disease
50%
Epileptic Seizure
50%
Cost-Effectiveness Analysis
33%
Drug Resistant Epilepsy
33%
Logistic Regression Analysis
16%
Analysis of Variance
16%
Combination Therapy
16%
Mixed Model
16%
Effectiveness Study
16%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Drug Resistant Epilepsy
66%
Combination Therapy
33%
Effectiveness Study
33%
Mixed Model
33%
Immunology and Microbiology